Penn Mutual Asset Management’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-6,298
Closed -$421K – 75
2024
Q2
$421K Sell
6,298
-6,600
-51% -$449K 0.89% 29
2024
Q1
$917K Sell
12,898
-40,195
-76% -$3.01M 1.96% 10
2023
Q4
$4.47M Buy
53,093
+16,810
+46% +$1.39M 3.45% 4
2023
Q3
$3.12M Buy
36,283
+6,000
+20% +$554K 2.93% 9
2023
Q2
$2.82M Buy
30,283
+16,335
+117% +$1.54M 2.54% 13
2023
Q1
$1.32M Buy
13,948
+11,648
+506% +$1.07M 1.25% 30
2022
Q4
$231K Buy
+2,300
New +$210K 0.26% 56

Other funds holding UTMD

Penn Mutual Asset Management's UTMD Position: Q3 2024 in Review

Penn Mutual Asset Management sold out of Utah Medical Products (UTMD) in Q3 2024, closing a stake of 6,298 shares — an estimated $421K sold.

Penn Mutual Asset Management first reported a position in UTMD in Q4 2022 and held it in 7 quarters. The position peaked at $4.47M in Q4 2023. 112 funds tracked by Wall St. Rank hold UTMD as of Q3 2024.

  • Penn Mutual Asset Management reported no remaining Utah Medical Products position as of Q3 2024 after selling out during the quarter.
  • Penn Mutual Asset Management sold 6,298 Utah Medical Products shares in Q3 2024, an estimated $421K.
  • Penn Mutual Asset Management first reported a position in Utah Medical Products in Q4 2022 and held it in 7 quarters.
  • Penn Mutual Asset Management's Utah Medical Products position peaked at $4.47M in Q4 2023.
  • 112 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2024.

Based on Penn Mutual Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.